Search Results 1231-1240 of 17468 for Carcinogen
ROCHESTER, Minn. — A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor ...
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...
Mayo Clinic researchers lead transformative shift toward neurorestorative treatment strategies for most severe forms of epilepsy · Advancing medicine one lab ...
The need for better options in diabetes care inspires Kyle Knofczynski, a student in the Regenerative Sciences Ph.D. track at the Mayo Clinic Graduate ...
Mayo Clinic seeks to harness the power of cells, tissue and genes by delivering first-of-their kind therapeutics for patients in early-stage clinical trials.
ROCHESTER, Minn. — For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in[.
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “Y” to learn about drug side effects, proper use and ...
Advancing understanding of CAR-T cell therapy for cancer. This article on a Mayo Clinic Regenerative Sciences Training Program student is taken from a ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “S” to learn about drug side effects, proper use and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.